BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 33720688)

  • 21. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing the targeting scope and efficiency of base editing with Proxy-BE strategy.
    Liu Y; Li G; Yang G; Gu H; Huang S; Yu W; Qin G; Liu X; Zhou F; Huang X; Wei Y
    FEBS Lett; 2020 Apr; 594(8):1319-1328. PubMed ID: 31837228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systems Analysis of Highly Multiplexed CRISPR-Base Editing in Streptomycetes.
    Whitford CM; Gren T; Palazzotto E; Lee SY; Tong Y; Weber T
    ACS Synth Biol; 2023 Aug; 12(8):2353-2366. PubMed ID: 37402223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Web-based design and analysis tools for CRISPR base editing.
    Hwang GH; Park J; Lim K; Kim S; Yu J; Yu E; Kim ST; Eils R; Kim JS; Bae S
    BMC Bioinformatics; 2018 Dec; 19(1):542. PubMed ID: 30587106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exogenous gene integration mediated by genome editing technologies in zebrafish.
    Morita H; Taimatsu K; Yanagi K; Kawahara A
    Bioengineered; 2017 May; 8(3):287-295. PubMed ID: 28272984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR-Cas9 Based Engineering of Actinomycetal Genomes.
    Tong Y; Charusanti P; Zhang L; Weber T; Lee SY
    ACS Synth Biol; 2015 Sep; 4(9):1020-9. PubMed ID: 25806970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. dCas9 binding inhibits the initiation of base excision repair in vitro.
    Antony JS; Roberts SA; Wyrick JJ; Hinz JM
    DNA Repair (Amst); 2022 Jan; 109():103257. PubMed ID: 34847381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in
    Zhang WW; Matlashewski G
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31434745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Target binding and residence: a new determinant of DNA double-strand break repair pathway choice in CRISPR/Cas9 genome editing.
    Feng Y; Liu S; Chen R; Xie A
    J Zhejiang Univ Sci B; 2021 Jan; 22(1):73-86. PubMed ID: 33448189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies.
    Li J; Tang C; Liang G; Tian H; Lai G; Wu Y; Liu S; Zhang W; Liu S; Shao H
    Hum Gene Ther; 2023 Dec; 34(23-24):1190-1203. PubMed ID: 37642232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions.
    Kim YB; Komor AC; Levy JM; Packer MS; Zhao KT; Liu DR
    Nat Biotechnol; 2017 Apr; 35(4):371-376. PubMed ID: 28191901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-efficient and precise base editing of C•G to T•A in the allotetraploid cotton (Gossypium hirsutum) genome using a modified CRISPR/Cas9 system.
    Qin L; Li J; Wang Q; Xu Z; Sun L; Alariqi M; Manghwar H; Wang G; Li B; Ding X; Rui H; Huang H; Lu T; Lindsey K; Daniell H; Zhang X; Jin S
    Plant Biotechnol J; 2020 Jan; 18(1):45-56. PubMed ID: 31116473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving Plant Genome Editing with High-Fidelity xCas9 and Non-canonical PAM-Targeting Cas9-NG.
    Zhong Z; Sretenovic S; Ren Q; Yang L; Bao Y; Qi C; Yuan M; He Y; Liu S; Liu X; Wang J; Huang L; Wang Y; Baby D; Wang D; Zhang T; Qi Y; Zhang Y
    Mol Plant; 2019 Jul; 12(7):1027-1036. PubMed ID: 30928637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cas9-NG Greatly Expands the Targeting Scope of the Genome-Editing Toolkit by Recognizing NG and Other Atypical PAMs in Rice.
    Ren B; Liu L; Li S; Kuang Y; Wang J; Zhang D; Zhou X; Lin H; Zhou H
    Mol Plant; 2019 Jul; 12(7):1015-1026. PubMed ID: 30928635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond Native Cas9: Manipulating Genomic Information and Function.
    Mitsunobu H; Teramoto J; Nishida K; Kondo A
    Trends Biotechnol; 2017 Oct; 35(10):983-996. PubMed ID: 28739220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing.
    Li J; Hong S; Chen W; Zuo E; Yang H
    J Genet Genomics; 2019 Nov; 46(11):513-521. PubMed ID: 31911131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/dCas9-Mediated Multiplex Gene Repression in Streptomyces.
    Zhao Y; Li L; Zheng G; Jiang W; Deng Z; Wang Z; Lu Y
    Biotechnol J; 2018 Sep; 13(9):e1800121. PubMed ID: 29862648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide target specificities of CRISPR RNA-guided programmable deaminases.
    Kim D; Lim K; Kim ST; Yoon SH; Kim K; Ryu SM; Kim JS
    Nat Biotechnol; 2017 May; 35(5):475-480. PubMed ID: 28398345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR-Cas immunity, DNA repair and genome stability.
    Cubbon A; Ivancic-Bace I; Bolt EL
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30209206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
    Tapscott T; Guarnieri MT; Henard CA
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.